EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Delta Asia International Corporation (6762) fair value: what the stock is really worth

We calculate from audited financials what Delta Asia International Corporation is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · TW

DA Broad data Sep 13, 2026

Delta Asia International Corporation

6762 · TWO

Weakest SetupQuality growthStrongly overvalued and low quality.

!Fair value 40.07 TWD · Strongly overvalued (−75%)
!Quality 36/100
!Expensive Growth (revenue 5y +4.6 %/yr)
!Thin margins · 2.6% net margin (TTM)
Low debt · generates free cash flow
·0.31% dividend yield
!Trails peers (2/14)
!Narrow moat 37/100
!Weak on past: 5 out of 100
!Weak on dividend: 6 out of 100
Watch Delta Asia International Corporation for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

300.50 TWD 142.00 TWD Fair Value 40.07 TWD Dec 2020 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

60‑month range 142.00 TWD – 300.50 TWD · fair‑value band 31.30 TWD – 40.07 TWD · the 161.00 TWD price screens above the 40.07 TWD fair value. Dashed = 300-day average. As of Sep 13, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Delta Asia International Corporation engages in manufacturing and selling medical device parts and equipment in Taiwan. The company was founded in 2004 and is based in Taoyuan City, Taiwan.

Stock analysis

Delta Asia International Corporation (6762) currently trades at 161.00 TWD, while our model-based Fair Value estimate is 40.07 TWD, implying the stock looks roughly 301.8% overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 32.49 TWD per share, and 0 of the 26 models we run sit above the 161.00 TWD price.

Bear case: the Economic Profit group reads lowest at 7.23 TWD, and 26 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: 31.30 TWD (bear) to 40.07 TWD (bull), the price of 161.00 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Delta Asia International Corporation reported revenue of 694M TWD in FY2025 versus 531M TWD in FY2021, a compound +6.9%/yr. Reported net income was 23.4M TWD in FY2025, compounding −34.9%/yr from FY2021.

Key figures

Market cap 5.7B TWD (≈ $178M) · P/E ratio 255.6 · P/S ratio 8.63 · EPS (TTM) 0.6300 TWD · Dividend yield 0.3% · Net margin 3.4% · Return on equity −0.2% · Return on assets (EBIT) 6.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).

What moves the price

The share trades about 35% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 0% fair-value upside, at −75%, 6762 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (3.75 TWD to 117.69 TWD). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 31.30 TWD Fair Value 40.07 TWD Bull 40.07 TWD
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 8 months old). Earnings retained since then (0.1197 TWD per share) are deliberately not added. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income 24.50 TWD 23.06 TWD 17.53 TWD 76
FCF DCF 24.84 TWD 49.00 TWD 100.78 TWD 75
Growth DCF 24.11 TWD 49.88 TWD 88.27 TWD 75
All 26 models by family
DCF Models
FCF DCF 24.84 TWD 49.00 TWD 100.78 TWD 75
Owner Earnings 32.65 TWD 67.00 TWD 129.36 TWD 72
5Y Revenue Exit 15.35 TWD 29.36 TWD 48.67 TWD 70
5Y EBITDA Exit 55.72 TWD 117.69 TWD 200.20 TWD 72
5Y P/E Exit 12.05 TWD 22.14 TWD 33.82 TWD 69
10Y Revenue Exit 17.77 TWD 32.49 TWD 55.96 TWD 64
10Y EBITDA Exit 45.12 TWD 97.99 TWD 187.45 TWD 64
10Y P/E Exit 16.09 TWD 27.14 TWD 43.08 TWD 62
Earnings-Based
Graham-Dodd 4.31 TWD 24.24 TWD 33.67 TWD 63
Lynch FV 6.79 TWD 9.70 TWD 12.61 TWD 61
PEG = 1.0 6.79 TWD 9.70 TWD 12.61 TWD 57
EPV 5.74 TWD 7.23 TWD 8.52 TWD 74
Dividend Discount
Gordon GGM 2.18 TWD 4.34 TWD 6.58 TWD 67
DDM Multi-Stage 2.18 TWD 3.75 TWD 4.58 TWD 67
Multiples
P/E Multiple 10.47 TWD 13.96 TWD 17.45 TWD 63
P/S Multiple 8.09 TWD 10.78 TWD 13.48 TWD 58
P/B Multiple 8.09 TWD 10.78 TWD 13.48 TWD 55
EV/EBIT 16.67 TWD 23.46 TWD 30.26 TWD 65
EV/EBITDA 74.60 TWD 100.70 TWD 126.81 TWD 67
EV/Revenue 10.83 TWD 17.07 TWD 23.30 TWD 53
Asset-Based
NCAV (Graham) 17.78 TWD 23.82 TWD 35.56 TWD 54
Growth DCF
Growth DCF 24.11 TWD 49.88 TWD 88.27 TWD 75
Rev-Margin DCF 15.35 TWD 29.04 TWD 47.87 TWD 70
Economic Profit
Residual Income 24.50 TWD 23.06 TWD 17.53 TWD 76
ROIC Compounder 5.74 TWD 7.23 TWD 8.52 TWD 72
Growth Earnings
Growth-Adj P/E 10.40 TWD 14.86 TWD 19.31 TWD 67

Open the full fair value analysis →

Notify me when 6762 reaches fair value

Put 6762 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 36/100

Of which business quality 39 · Market factors (momentum, volatility) 37

Profitability 18
Margins and returns on capital today
Quality Growth 58
Are margins and returns improving?
Cashflow 64
Earnings quality: real cash, not paper profit
Fin. Strength 51
Balance sheet, leverage, solvency risk
Investment 35
Disciplined investing over empire-building
Low Volatility 68
Calm price path (market factor)
Momentum 29
Price trend over the last 3–12 months (market factor)
52W Momentum 14
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+19.6%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.5%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
Revenue growth 8 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.0%
What shareholders gained per year (last 5 years), in TWD What the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−35.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−35.6%
Dividend (yield on the price)0.3%
Profit margin 2020 to 2025 Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.45% → 9%

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes This turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+42.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.

6762 screens 302% overvalued. Compare with Abbott Laboratories, →

Compare Delta Asia International Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 356 stocks

Beats the industry median on 2/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 35 · Bottom 25%
Profitability
Return on equity (TTM) 1% · Below median
Return on assets 1% · Below median
Net margin (TTM) 3% · Below median
Operating margin (TTM) 15% · Above median
Growth and dividend
Revenue growth 6% · Below median
Dividend yield (TTM) 0.3% · Bottom 25%
Balance sheet
Debt / equity 0.24× · Above median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/E (TTM) 255.6× · Priciest 25%
P/B 4.58× · Priciest 25%
P/S (TTM) 8.88× · Priciest 25%
P/FCF 2.4× · Cheaper than median
EV/EBITDA 27.2× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 6
FUTURE (revenue growth)31 · sector 31
PAST (return on equity)5 · sector 8
HEALTH (low debt)88 · sector 97
DIVIDEND (yield)6 · sector 37

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $101.95 $74.79 −27%
Stryker Corporation SYK $275.56 $303.12 +10%
Medtronic plc MDT $90.96 $65.57 −28%
Boston Scientific Corporation BSX $42.98 $47.28 +10%
Edwards Lifesciences Corporation EW $84.37 $82.04 −3%
Siemens Healthineers AG SHL €38.23 €33.87 −11%
DexCom, Inc DXCM $83.03 $91.33 +10%
GE HealthCare Technologies Inc GEHC $63.93 $64.13 +0%
Koninklijke Philips N.V PHIA €21.14 €14.36 −32%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥162.73 ¥179.00 +10%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Delta Asia International Corporation Fair Value". https://www.fairvalue-calculator.com/stock/6762

Frequently asked questions

Is Delta Asia International Corporation (6762) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 40.07 TWD versus a price of 161.00 TWD, about −75% upside (overvalued).
What is the fair value of 6762?
Our model-based fair value for Delta Asia International Corporation is 40.07 TWD (as of Sep 13, 2026), built from audited fundamentals. The current price: 161.00 TWD.
What is the quality score of 6762?
Delta Asia International Corporation has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Delta Asia International Corporation (6762)?
Our model-based price target is the fair value of 40.07 TWD (as of Sep 13, 2026) from 26 valuation models. Cautious scenario 31.30 TWD, optimistic scenario 40.07 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Delta Asia International Corporation stock forecast for 2026?
Our models put fair value at 40.07 TWD, about −75% upside versus a price of 161.00 TWD (overvalued). Cautious scenario 31.30 TWD, optimistic scenario 40.07 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Delta Asia International Corporation (6762)?
Delta Asia International Corporation reported trailing-twelve-month revenue of about 666M TWD (latest available figure, as of Sep 13, 2026).
Does Delta Asia International Corporation pay a dividend?
Delta Asia International Corporation currently shows a dividend yield of about 0.31% relative to its recent price (as of Sep 13, 2026).
What growth is priced into Delta Asia International Corporation (6762)?
For today's price to be fair in a discounted-cash-flow model, Delta Asia International Corporation would have to grow free cash flow by +42.8 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.6 % per year. As of Sep 13, 2026.
What discount rate (WACC) does the fair value of 6762 use?
Our models discount Delta Asia International Corporation at 11.8 %: a base by market capitalisation (micro), damped by beta 0.21, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Delta Asia International Corporation that is +42.8 % per year a year over ten years, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Delta Asia International Corporation (6762) delivered so far?
Over the past 5 years revenue at Delta Asia International Corporation grew +4.6 % a year. The price currently implies +42.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Delta Asia International Corporation (6762) growing?
The median revenue growth in the sector is +4.3 % a year. That is the yardstick for the growth priced into Delta Asia International Corporation (+42.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Delta Asia International Corporation (6762)?
The free-cash-flow yield on the price is 1.40 %: that much free cash flow Delta Asia International Corporation produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Delta Asia International Corporation (6762)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Delta Asia International Corporation it is 40.07 TWD per share (as of Sep 13, 2026), against a price of 161.00 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Delta Asia International Corporation stock overvalued or undervalued in 2026?
As of Sep 13, 2026, 6762 trades above its calculated fair value: price 161.00 TWD, fair value 40.07 TWD, a gap of about −75% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6762?
No. The price is what the market pays today (161.00 TWD); the fair value is what the company's own numbers justify (40.07 TWD). For Delta Asia International Corporation the two are 120.93 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Delta Asia International Corporation worth?
The market values Delta Asia International Corporation at about 5.7B TWD (market capitalisation, as of Sep 13, 2026). Per share that is 161.00 TWD; our models calculate a fair value of 40.07 TWD per share.
What do the bullish and bearish scenarios say about 6762?
Our models span a range for Delta Asia International Corporation: cautious scenario 31.30 TWD, base 40.07 TWD, optimistic 40.07 TWD per share (as of Sep 13, 2026, price 161.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6762?
Delta Asia International Corporation trades at a price-to-earnings ratio of 255.6 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 40.07 TWD is built from several models across several years. Other multiples: P/B 4.6, P/S 8.9, EV/EBITDA 27.2.
How solid is the balance sheet of Delta Asia International Corporation (6762)?
Balance-sheet figures for Delta Asia International Corporation (as of Sep 13, 2026): return on equity 1.4%, debt of 0.24 per unit of equity. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is 6762 from its 52-week high?
Delta Asia International Corporation trades at 161.00 TWD, about 35% below its 52-week high of 248.00 TWD and 17% above the low of 138.00 TWD (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 40.07 TWD is for.
Which stocks are comparable to Delta Asia International Corporation?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Delta Asia International Corporation stock attractive at the current price?
The data as of Sep 13, 2026: price 161.00 TWD, calculated fair value 40.07 TWD (−75%), Quality Score 36/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6762 calculated?
We run Delta Asia International Corporation through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 40.07 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Delta Asia International Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Delta Asia International Corporation right now?
The price sits above even our optimistic bull case (40.07 TWD). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts.

Key figures of Delta Asia International Corporation

How large is the market capitalisation of Delta Asia International Corporation (6762)?
The market capitalisation of Delta Asia International Corporation is 5.7B TWD (≈ $178M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Delta Asia International Corporation (6762)?
The price-to-sales ratio of Delta Asia International Corporation is 8.63 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Delta Asia International Corporation (6762)?
Earnings per share at Delta Asia International Corporation are 0.6300 TWD (price ÷ EPS = P/E 255.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Delta Asia International Corporation (6762)?
The dividend yield of Delta Asia International Corporation is 0.3% (payout 79.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Delta Asia International Corporation (6762)?
The net margin of Delta Asia International Corporation is 3.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Delta Asia International Corporation (6762)?
The return on equity (ROE) of Delta Asia International Corporation is −0.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Delta Asia International Corporation (6762)?
On an EBIT basis the return on assets of Delta Asia International Corporation is 6.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Delta Asia International Corporation (6762)?
The operating margin of Delta Asia International Corporation is −9.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Delta Asia International Corporation (6762)?
Revenue at Delta Asia International Corporation is growing −17.0% versus a year earlier (3y avg +14.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Delta Asia International Corporation (6762)?
Earnings per share at Delta Asia International Corporation are growing +114% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Delta Asia International Corporation (6762) carry?
The net debt of Delta Asia International Corporation is 903M TWD (fiscal year 2025, ≈ 11.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Delta Asia International Corporation in the live analysis

One click puts Delta Asia International Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.